首页> 外文期刊>World Journal of Gastroenterology >Expression of G3BP and RhoC in esophageal squamous carcinoma and their effect on prognosis
【24h】

Expression of G3BP and RhoC in esophageal squamous carcinoma and their effect on prognosis

机译:G3BP和RhoC在食管鳞癌中的表达及其对预后的影响

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To investigate the expression and significance of G3BP and RhoC proteins in esophageal squamous carcinoma (ESC).rnMETHODS: The expression of G3BP and Rhoc proteins in 80 cases of ESC was detected by immunohistochemistry. The relationship was studied between the expression of the two proteins and tumor size, differentiation degree, TNM stage, lymph node metastasis and prognosis of ESC.rnRESULTS: The positive expression rate of G3BP in ESC was 71.25%; and the rate in the lymph node metastasis group was significantly higher than that in the non-lymph node metastasis group (Z = -2.283, P = 0.022), but no relations were found between G3BP expression and tumor size, differentiation degree and TNM stage (P > 0.05). The group with G3BP positive expression had shorter survival time than the group with G3BP negative expression (P = 0.000). The positive expression rate of RhoC in ESC was 66.25%; and the rate in the lymph node metastasis group was significantly higher than that in the non-lymph node metastasis group (Z = -2.115, P < 0.05), but no relations were found between RhoC expression and tumor size, differentiation degree and TNM stage (P > 0.05). The RhoC positive expression group had a shorter survival time than the RhoC negative expression group (P < 0.001. The expression of G3BP protein correlated positively with the expression of RhoC in ESC tissues (r_s = 0.656, P < 0.001).rnCONCLUSION: The expression of G3BP and RhoC protein is closely related to the lymph node metastasis and survival in ESC patients. G3BP and RhoC proteins can be considered as predictors of prognosis in ESC patients.
机译:目的:探讨G3BP和RhoC蛋白在食管鳞癌(ESC)中的表达及其意义。方法:采用免疫组织化学方法检测80例ESC中G3BP和Rhoc蛋白的表达。研究了这两种蛋白的表达与肿瘤的大小,分化程度,TNM分期,淋巴结转移和ESC的预后之间的关系。结果:G3BP在ESC中的阳性表达率为71.25%;在ESC中阳性表达率为71.25%。淋巴结转移组的发生率明显高于非淋巴结转移组(Z = -2.283,P = 0.022),但G3BP的表达与肿瘤的大小,分化程度和TNM分期无关(P> 0.05)。 G3BP阳性表达组的生存时间比G3BP阴性表达组的生存时间短(P = 0.000)。 RhoC在ESC中的阳性表达率为66.25%;淋巴结转移组的发生率明显高于非淋巴结转移组(Z = -2.115,P <0.05),但RhoC的表达与肿瘤的大小,分化程度和TNM分期无关(P> 0.05)。 RhoC阳性表达组的存活时间短于RhoC阴性表达组(P <0.001。G3BP蛋白的表达与ESC组织中RhoC的表达呈正相关(r_s = 0.656,P <0.001)。 G3BP和RhoC蛋白的表达与ESC患者的淋巴结转移和生存密切相关,G3BP和RhoC蛋白可作为ESC患者预后的预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号